RIPK3/RIP3 Antibody - BSA Free

Western Blot: RIPK3/RIP3 Antibody [NBP1-77299] - Analysis of RIP3 in HeLa cell lysate with RIPK3/RIP3 antibody [NBP1-77299] at (A) 1 and (B) 2 ug/mL. Observed molecular weight ~60 kDa. Theoretical molecular weight 53 kDa.

Western Blot: RIPK3/RIP3 Antibody [NBP1-77299] - Mouse Cell lines. 15 ug of lysates per lane. Antibodies: [NBP1-77299], (0.5 ug/mL), 1h incubation at RT in 5% NFDM/TBST. Secondary: Goat anti-rabbit IgG HRP conjugate at 1:10000 dilution. Observed molecular weight ~50 kDa. Theoretical molecular weight 53 kDa.

Western Blot: RIPK3/RIP3 Antibody [NBP1-77299] - Analysis using RIPK3/RIP3 antibody [NBP1-77299]. L929 cell line (mouse). 20 ug whole cell lysate. Primary antibody: 1:2000. Secondary antibody: 1:20000. Western blot image submitted by a verified customer review. Observed molecular weight ~57 kDa. Theoretical molecular weight 53 kDa.

Western Blot: RIPK3/RIP3 Antibody [NBP1-77299] - C2C12 Cells. 15 ug of lysates per lane. Antibodies: RIPK3/RIP3 antibody [NBP1-77299], 1h incubation at RT in 5% NFDM/TBST. Secondary: Goat anti-rabbit IgG HRP conjugate at 1:10000 dilution. Lane 1: NBP1-77299, 0.1 ug/mL in the presence of peptide blocking. Lane 2: NBP1-77299, 0.1 ug/mL Lane 3: NBP1-77299, 0.2 ug/mL Lane 4: NBP1-77299, 0.5 ug/mL. Observed molecular weight ~55 kDa. Theoretical molecular weight 53 kDa.

Western Blot: RIPK3/RIP3 Antibody [NBP1-77299] - Bone-marrow-derived macrophages exhibit significant reduction in RIPK3/RIP3 levels in RIPK3/RIP3deltaGlobal, RIPK3/RIP3deltaMphi-Cre and RIPK3/RIP3deltaEC-Cre mice. Protein lysates were immunoblotted to identify CD11b, RIPK3/RIP3 and beta-actin (loading control). Image collected and cropped by CiteAb from the following publication (www.dmm.biologists.org/lookup/doi/10.1242/dmm.041962) licensed under a CC-BY license.

Knockdown Validated: RIPK3/RIP3 Antibody [NBP1-77299] - RIPK3/RIP3-deficiency impacts MCP-1 and IL-1beta expression in BMDMs and MCP-1 and E-Selectin/CD62E expression in cultured endothelial cells. Protein lysates were immunoblotted for RIPK3/RIP3 and the loading control, GAPDH (n=4 independent experiments). Image collected and cropped by CiteAb from the following publication (www.dmm.biologists.org/content/13/1/dmm041962) licensed under a CC-BY license.

Western Blot: RIPK3/RIP3 Antibody - BSA Free [NBP1-77299] - Bone-marrow-derived macrophages exhibit significant reduction in RIPK3 levels in Ripk3 delta Global, Ripk3 delta MΦ-Cre & Ripk3 delta EC-Cre mice. (A,B) BMDMs were isolated, differentiated on chamber slides for 7 days, immunostained for macrophage markers CD68 (red; A) & CD11b (pink; B), & co-stained for nuclei (Hoechst; blue). All cells from seven separate BMDM isolations were positive for these markers (n=7). (C) A phagocytosis assay was performed on BMDMs with fluorescent polystyrene beads. Phagocytic cells display TRITC+/Hoechst+ signal, & 85% of cells from two separate BMDM isolations were double positive (n=2). (D-F) Protein or RNA was collected from control, Ripk3 delta Global, Ripk3 delta MΦ-Cre & Ripk3 delta EC-Cre BMDMs. RNA was converted to cDNA & analyzed by qPCR for Ripk3 levels (D). Protein lysates were immunoblotted to identify CD11b, RIPK3 & beta -actin (loading control) (E) & quantified (F). (G) RNA from control & Ripk3 delta Global BMDMs was converted to cDNA & analyzed by qPCR for Ripk3-Exon 10 levels. For panels D,F,G, each dot represents a BMDM isolation from an individual animal. Statistics for panels D & F were calculated using one-way ANOVA with Dunnett's multiple comparisons test. Overall ANOVA P-values (prior to the post hoc tests) are 0.0002 (D) & <0.0001 (F). Statistics for panel G were calculated using an unpaired t-test with Welch's correction. *P<0.05, **P<0.01, ***P<0.001, ****P<0.0001. Data are mean±s.d. Scale bars: 25 µm. Image collected & cropped by CiteAb from the following publication (//pubmed.ncbi.nlm.nih.gov/31953345), licensed under a CC-BY license. Not internally tested by Novus Biologicals.

Western Blot: RIPK3/RIP3 Antibody - BSA Free [NBP1-77299] - p-MLKL levels are nearly undetectable in advanced plaques. (A-C) After 3 months on a Western diet, protein was collected from control (n=7), Ripk3 delta MΦ-Cre (n=5), Ripk3 delta EC-Cre (n=3) & Ripk3 delta SMC-Cre (n=3) aortas. Protein lysates were immunoblotted to identify p-MLKL (Abcam; #ab196436), MLKL & beta -actin (loading control) (A) & quantified (B,C). A faint positive p-MLKL signal can be seen in the representative blot in the control arch region; however, we could only detect p-MLKL in two out of the 18 aortas analyzed (B). Note that the same transfer membrane used for detecting CD11b (in Fig. 4S) was reprobed for p-MLKL & MLKL in A; the beta -actin control blots are therefore the same in both figures. (D,E) Protein lysates were immunoblotted to identify RIPK3 & GAPDH (loading control) (D) & quantified (E). For panels B,C,E, each dot represents an individual animal. Statistics were calculated using two-way ANOVA. Overall ANOVA P-values are 0.76 (B), 0.07 (C) & 0.46 (E). Data are mean±s.d. Image collected & cropped by CiteAb from the following publication (//pubmed.ncbi.nlm.nih.gov/31953345), licensed under a CC-BY license. Not internally tested by Novus Biologicals.

Immunocytochemistry/ Immunofluorescence: RIPK3/RIP3 Antibody - BSA Free [NBP1-77299] - Validation of RIPK3/RIP3 in Rat Kidney Tissue. Immunofluorescent analysis of 4% paraformaldehyde-fixed Rat Kidney tissue labeling RIPK3/RIP3 with at 20 ug/mL, followed by goat anti-rabbit IgG secondary antibody at 1/500 dilution (red).

Immunohistochemistry: RIPK3/RIP3 Antibody - BSA Free [NBP1-77299] - Validation of RIPK3/RIP3 in Mouse Kidney Tissue. Immunohistochemical analysis of paraffin-embedded mouse kidney tissue using anti-RIPK3/RIP3 antibody at 2.5 ug/ml. Tissue was fixed with formaldehyde and blocked with 10% serum for 1 h at RT; antigen retrieval was by heat mediation with a citrate buffer (pH6). Samples were incubated with primary antibody overnight at 4C. A goat anti-rabbit IgG H&L (HRP) at 1/250 was used as secondary. Counter stained with Hematoxylin.

Immunohistochemistry: RIPK3/RIP3 Antibody - BSA Free [NBP1-77299] - Validation of RIPK3/RIP3 in Rat Kidney Tissue.Immunohistochemical analysis of paraffin-embedded rat kidney tissue using anti-RIPK3/RIP3 antibody at 5 ug/ml. Tissue was fixed with formaldehyde and blocked with 10% serum for 1 h at RT; antigen retrieval was by heat mediation with a citrate buffer (pH6). Samples were incubated with primary antibody overnight at 4C. A goat anti-rabbit IgG H&L (HRP) at 1/250 was used as secondary. Counter stained with Hematoxylin.

Western Blot: RIPK3/RIP3 Antibody - BSA Free [NBP1-77299] - Validation in Human Cell Lines. Loading: 15 ug of lysates per lane.Antibodies: RIPK3/RIP3 , (0.5 ug/mL), 1h incubation at RT in 5% NFDM/TBST.Secondary: Goat anti-rabbit IgG HRP conjugate at 1:10000 dilution.

• Reactivity: Hu, Mu, Rt
• Applications: WB, Simple Western, ELISA, ICC/IF, IHC, IP, GS, KD, KO
• Clonality: Polyclonal
• Host: Rabbit
• Conjugate: Unconjugated
• Format: BSA Free
• Concentration: 1 mg/ml

RIPK3/RIP3 Antibody - BSA Free Summary

• Immunogen: RIPK3/RIP3 Antibody was made to a 14 amino acid peptide near the carboxy terminus of murine RIP3. The immunogen is located within the last 50 amino acids of RIP3. Amino Acid Squence: AQFGRGRGWQPFHK
• Specificity: Mouse RIPK3/RIP3 Antibody has one isoform (486aa, 53 kDa). Human RIP3 has 3 isoforms, including isoform 1 (518aa, 57 kDa), isoform 2 (252aa, 28 kDa) and isoform 3 (231aa, 25 kDa). Rat RIP3 also has one isoform (478aa, 52 kDa). NBP1-77299 can detect can detect isoforms of mouse and rat as well as human isoform 1.
• Isotype: IgG
• Clonality: Polyclonal
• Host: Rabbit
• Gene: RIPK3
• Purity: Peptide affinity purified

Applications/Dilutions

• Dilutions:
  • ELISA 1:100 - 1:2000
  • Gel Supershift Assay
  • Immunocytochemistry/ Immunofluorescence 20 ug/ml
  • Immunohistochemistry 5 ug/ml
  • Immunohistochemistry-Paraffin 5 ug/ml
  • Immunoprecipitation 20 ug/mL
  • Knockdown Validated
  • Knockout Validated
  • Simple Western 1:25
  • Western Blot 0.1-0.5 ug/ml
• Application Notes: Gel supershift assay reported in scientific literature [PMID: 27721066]. Immunoprecipitation reported in scientific literature [PMID: 27861127]. RIPK3/RIP3 antibody validated for WB from a verified customer review. Knockout validation reported in scientific literature [PMID: 32246911]. Knockdown validation reported in scientific literature [PMID: 31655343]. ICC/IF, IHC, and WB reported in multiple pieces of scientific literature.
• Theoretical MW: 53 kDa.
  Disclaimer note: The observed molecular weight of the protein may vary from the listed predicted molecular weight due to post translational modifications, post translation cleavages, relative charges, and other experimental factors.
• Control Peptide:

  RIPK3/RIP3 Protein (NBP1-77299PEP)

Reactivity Notes

Human, mouse and rat reactivity reported in multiple pieces of scientific literature.

Packaging, Storage & Formulations

• Storage: Store at 4C.
• Buffer: PBS
• Preservative: 0.02% Sodium Azide
• Concentration: 1 mg/ml
• Purity: Peptide affinity purified

Alternate Names for RIPK3/RIP3 Antibody - BSA Free

• EC 2.7.11.1
• Receptor Interacting Serine/Threonine Kinase 3
• Receptor-interacting protein 3
• receptor-interacting serine/threonine-protein kinase 3
• receptor-interacting serine-threonine kinase 3
• RIP3
• RIP-3
• RIPK3
• RIP-like protein kinase 3

Background

RIPK3, Receptor interacting serine/threonine kinase 3 or RIP-like protein kinase 3 (human RIPK3 isoform1 theoretical molecular weight 57kDa) is a cytosolic protein with an amino terminal active kinase domain. RIP kinases, RIPK1 and RIPK3 play a central role in the induction of necroptosis, a form of programmed and inflammatory cell death that is caspase-independent (1). Necroptosis is a form of programmed necrosis which is initiated through the activation of RIPK3 by various ligands such as Fas, LPS and TNF. Formation of the necrosome results from the interaction between RIPK1 and RIPK3 mediated through their RIP homotypic interaction motifs (RHIMs) (1, 2). Following necrosome formation, RIPK3 activation leads to the phosphorylation of mixed lineage kinase domain-like protein (MLKL) which induces its oligomerization and translocation to the cell membrane where it alters plasma membrane integrity (2). Loss of membrane integrity results in lytic cell death, release of damage associated molecular patterns (DAMPs) and inflammation (2, 3). Therefore, the interaction of RIPK3 with other RHIM proteins is necessary for the initiation of necroptosis, while the execution phase is dependent on the activation of MLKL (4).

RIPK3 has several phosphorylation sites that are required for its role in necroptosis. For example, serine204 in mouse, which is conserved in the human (serine199), is necessary for necroptosis while serine residues 232 and 227 are both required for RIPK3s interaction with MLKL (2). The core necroptosis proteins RIPK1/RIPK3 and MLKL are implicated in several disease states such as neurodegeneration, cardiovascular, hepatic and pulmonary disease (3).

References

1. Orozco, S., & Oberst, A. (2017). RIPK3 in cell death and inflammation: the good, the bad, and the ugly. Immunological Reviews. https://doi.org/10.1111/imr.12536

2. Dhuriya, Y. K., & Sharma, D. (2018). Necroptosis: A regulated inflammatory mode of cell death. Journal of Neuroinflammation. https://doi.org/10.1186/s12974-018-1235-0

3. Choi, M. E., Price, D. R., Ryter, S. W., & Choi, A. M. K. (2019). Necroptosis: A crucial pathogenic mediator of human disease. JCI Insight. https://doi.org/10.1172/jci.insight.128834

4. Lee, K.-H., & Kang, T.-B. (2019). The Molecular Links between Cell Death and Inflammasome. Cells. https://doi.org/10.3390/cells8091057

Limitations

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.

Publications for RIPK3/RIP3 Antibody (NBP1-77299)(82)

Publications using NBP1-77299

• Selvarani R, Van Michelle Nguyen H, Thadathil N et al. Characterization of novel mouse models to study the role of necroptosis in aging and age-related diseases GeroScience 2023-10-04 [PMID: 37792157] (Western Blot, Mouse)
• Du Y, Zhong Y, Ding R et al. New insights of necroptosis and immune infiltration in sepsis-induced myocardial dysfunction from bioinformatics analysis through RNA-seq in mice Frontiers in Cellular and Infection Microbiology 2022-12-21 [PMID: 36619743] (Immunohistochemistry, Mouse)
• Liu h, Zhou H, Zhou L et al. Skp2-ubiquitinated MLKL degradation confers cisplatin-resistant in non-small cell lung cancer cells Research Square 2022-10-12 (WB, Human)
• Hänggi K, Li J, Gangadharan A, Liu X et Al. Interleukin-1? release during necrotic-like cell death generates myeloid-driven immunosuppression that restricts anti-tumor immunity Cancer Cell 2024-11-22 [PMID: 39577420]
• Liu Z, Sun L, Li L et Al. Pseudomonas aeruginosa Mediates Host Necroptosis through Rhl-Pqs Quorum Sensing Interaction Immunohorizons 2024-09-01 [PMID: 39312394]
• Nam, YW;Shin, JH;Kim, S;Hwang, CH;Lee, CS;Hwang, G;Kim, HR;Roe, JS;Song, J; EGFR inhibits TNF-?-mediated pathway by phosphorylating TNFR1 at tyrosine 360 and 401 Cell death and differentiation 2024-05-24 [PMID: 38789573]
• Jia Y, Cheng L, Yang J et al. miR-223-3p Prevents Necroptotic Macrophage Death by Targeting Ripk3 in a Negative Feedback Loop and Consequently Ameliorates Advanced Atherosclerosis Arteriosclerosis, thrombosis, and vascular biology 2023-11-16 [PMID: 37970714]
• Taraborrelli L, ?enbabao?lu Y, Wang L et al. Tumor-intrinsic expression of the autophagy gene Atg16l1 suppresses anti-tumor immunity in colorectal cancer Nat Commun 2023-09-23 [PMID: 37741832] (Western Blot, Human, Mouse)
• Zhou H, Zhou L, Guan Q et al. Skp2-mediated MLKL degradation confers cisplatin-resistant in non-small cell lung cancer cells Communications Biology 2023-08-02 [PMID: 37532777] (Western Blot, Human, Mouse)
• Wen H, Chen J, Zhao B et al. Repression of ferroptotic cell death by mitochondrial calcium signaling Research square 2023-07-10 [PMID: 37502961] (IP, WB, Human)
• Chen XC, Huang LF, Tang JX et Al. Asiatic acid alleviates cisplatin-induced renal fibrosis in tumor-bearing mice by improving the TFEB-mediated autophagy-lysosome pathway Biomed Pharmacother 2023-08-17 [PMID: 37413899]
• Mohammed S, Thadathil N, Ohene-Marfo P et al. Absence of either Ripk3 or Mlkl reduces incidence of hepatocellular carcinoma independent of liver fibrosis Molecular cancer research : MCR 2023-05-19 [PMID: 37204757] (WB, Mouse)
• Lyons JD, Mandal P, Otani S et al. The RIPK3 Scaffold Regulates Lung Inflammation During Pseudomonas Aeruginosa Pneumonia American journal of respiratory cell and molecular biology 2022-09-30 [PMID: 36178467] (WB)
• Hwang SM, Ha YJ, Koo GB et al. LCK-Mediated RIPK3 Activation Controls Double-Positive Thymocyte Proliferation and Restrains Thymic Lymphoma by Regulating the PP2A-ERK Axis Advanced science (Weinheim, Baden-Wurttemberg, Germany) 2022-09-25 [PMID: 36161785] (PLA, Mouse)
• Dong Y, Yu H, Li X et al. Hyperphosphorylated tau mediates neuronal death by inducing necroptosis and inflammation in Alzheimer's disease Journal of neuroinflammation 2022-08-15 [PMID: 35971179] (WB)
  
  Details:
  Dilutions: 1:1000
• Cacciola NA, Salzano A, D'Onofrio N et al. Buffalo Milk Whey Activates Necroptosis and Apoptosis in a Xenograft Model of Colorectal Cancer International journal of molecular sciences 2022-07-30 [PMID: 35955595] (WB)
  
  Details:
  Used with tissue from mice xenografted with HCT116 cells, dilution used 1:1000
• Yan WT, Zhao WJ, Hu XM et al. PANoptosis-like cell death in ischemia/reperfusion injury of retinal neurons Neural Regen Res 2022-07-28 [PMID: 35900430] (Western Blot, Human, Mouse)
• Abd El-Aal SA, AbdElrahman M, Reda AM et al. Galangin Mitigates DOX-induced Cognitive Impairment in Rats: Implication of NOX-1/Nrf-2/HMGB1/TLR4 and TNF-alpha/MAPKs/RIPK/MLKL/BDNF Neurotoxicology 2022-07-14 [PMID: 35843304] (WB, Rat)
  
  Details:
  adult male (8–10 weeks) Wistar rats
• Feng Y, Imam Aliagan A, Tombo N et al. RIP3 Translocation into Mitochondria Promotes Mitofilin Degradation to Increase Inflammation and Kidney Injury after Renal Ischemia-Reperfusion Cells 2022-06-11 [PMID: 35741025] (WB, Mouse)
• Lee J, Lee S, Min S, Kang SW. RIP3-Dependent Accumulation of Mitochondrial Superoxide Anions in TNF-?-Induced Necroptosis Molecules and Cells 2022-04-30 [PMID: 35289306] (Western Blot, Human, Mouse)
• Parshenkov A, Hennet T Glycosylation-Dependent Induction of Programmed Cell Death in Murine Adenocarcinoma Cells Frontiers in immunology 2022-02-10 [PMID: 35222379] (WB, Mouse)
• D'Onofrio N, Martino E, Balestrieri A et al. Diet-derived ergothioneine induces necroptosis in colorectal cancer cells by activating the SIRT3/MLKL pathway FEBS letters 2022-02-04 [PMID: 35122251] (WB, Human)
• Rudalska R, Harbig J, Snaebjornsson M et al. LXR alpha activation and Raf inhibition trigger lethal lipotoxicity in liver cancer Nature Cancer 2021-02-01 [PMID: 35122079]
• Peters E, Karver M, Sun K Et Al. Self Assembled Peptide Amphiphile Nanofibers for Controlled Therapeutic Delivery to the Atherosclerotic Niche Adv Ther (Weinh) 2021-12-20 [PMID: 34926792]
• Shi S, Verstegen MMA, Roest HP Et al. Recapitulating cholangiopathy-associated necroptotic cell death in vitro using human cholangiocyte organoids Cellular and molecular gastroenterology and hepatology 2021-10-23 [PMID: 34700031] (IF/IHC, ICC/IF, Human)
• Zou J, Shi Q, Chen H Et al. Programmed necroptosis is upregulated in low-grade myelodysplastic syndromes and may play a role in the pathogenesis Experimental hematology 2021-09-24 [PMID: 34563605] (IHC-P, Human)
• Thadathil N, Nicklas EH, Mohammed S et al. Necroptosis increases with age in the brain and contributes to age-related neuroinflammation GeroScience 2021-10-01 [PMID: 34515928] (Western Blot, Human, Mouse)
• Fu B, Lin X, Tan S Et Al. MiR-342 controls Mycobacterium tuberculosis susceptibility by modulating inflammation and cell death EMBO reports 2021-07-20 [PMID: 34288348] (WB, IP)
• Byun H, Kwon S, Wagner K et al. Tumor Susceptibility Gene 101 Is Required for the Maintenance of Uterine Epithelial Cells During Embryo Implantation Reprod Biol Endocrinol 2021-07-17 [PMID: 34271917]
• Xu H, Cai Y, Yu M Et Al. Celastrol protects against early brain injury after subarachnoid hemorrhage in rats through alleviating blood-brain barrier disruption and blocking necroptosis Aging 2021-06-28 [PMID: 34182541] (WB)
• Shao D, Li K, You M et al. Macrophage polarization by plasma sprayed ceria coatings on titanium-based implants: Cerium valence state matters iScience 2021-06-18 [PMID: 34142044] (Mouse)
• Garcia LR, Tenev T, Newman R et al. Ubiquitylation of MLKL at lysine 219 positively regulates necroptosis-induced tissue injury and pathogen clearance Nature communications 2021-06-07 [PMID: 34099649] (Mouse)
• Gao S, Griffin CT RIPK3 modulates growth factor receptor expression in endothelial cells to support angiogenesis Angiogenesis 2021-01-15 [PMID: 33449298]
• Baidya R, Gautheron J, Crawford DHG, et al. Inhibition of MLKL Attenuates Necroptotic Cell Death in a Murine Cell Model of Ischaemia Injury Journal of clinical medicine 2021-01-08 [PMID: 33435617]
• Dai Q, Zhang Y, Liao X et al. Fluorofenidone Alleviates Renal Fibrosis by Inhibiting Necroptosis Through RIPK3/MLKL Pathway Frontiers in pharmacology 2020-12-16 [PMID: 33390935] (WB, Mouse)
• Zhou H, Liu L, Ma X et al. RIP1/RIP3/MLKL-mediated necroptosis contributes to vinblastine-induced myocardial damage Molecular and Cellular Biochemistry 2021-02-01 [PMID: 33247805] (Western Blot, Human, Mouse)
• LingHu HR, Luo H, Gang L Bufalin Induces Glioma Cell Death by Apoptosis or Necroptosis Onco Targets Ther 2020-05-27 [PMID: 32581545] (IP, WB, Human)
• Seo J, Seong D, Nam YW et al. Beclin 1 functions as a negative modulator of MLKL oligomerisation by integrating into the necrosome complex Cell Death Differ. 2020-05-26 [PMID: 32457484] (WB, Mouse, Human)
• Lyu AR, Kim TH, Park SJ et al. Mitochondrial Damage and Necroptosis in Aging Cochlea Int J Mol Sci 2020-04-03 [PMID: 32260310] (IF/IHC, Mouse)
• Zhou H, Xu C, Lee H et al. Berardinelli-Seip congenital lipodystrophy 2/SEIPIN determines brown adipose tissue maintenance and thermogenic programing Mol Metab 2020-03-04 [PMID: 32246911] (WB, KO, Mouse)
• Colijn S, Muthukumar V, Xie J et al. Cell-specific and athero-protective roles for RIPK3 in a murine model of atherosclerosis Dis Model Mech 2020-01-17 [PMID: 31953345] (WB, Mouse)
• Popper B, Rammer MT, Gasparitsch M, et al. Neonatal obstructive nephropathy induces necroptosis and necroinflammation Sci Rep 2019-12-09 [PMID: 31819111] (WB, Mouse)
• Du XK, Ge WY, Jing R, Pan LH Necroptosis in pulmonary macrophages mediates lipopolysaccharide-induced lung inflammatory injury by activating ZBP-1 Int. Immunopharmacol. 2019-10-23 [PMID: 31655343] (KD, WB, Mouse)
• Takezaki A, Tsukumo S I et al. A homozygous SFTPA1 mutation drives necroptosis of type II alveolar epithelial cells in patients with idiopathic pulmonary fibrosis. J Exp Med 2019-02-12 [PMID: 31601679] (IP, Mouse)
• RIPK3 Activation Leads to Cytokine Synthesis That Continues After Loss of Cell Membrane Integrity Orozco SL, Daniels BP, Yatim N et al. Cell Rep [PMID: 31461645] (WB, Mouse)
• The Neuroprotective Effects of Necrostatin-1 on Subarachnoid Hemorrhage in Rats Are Possibly Mediated by Preventing BloodBrain Barrier Disruption and RIP3-Mediated Necroptosis Chen J, Jin H, Xu H et al. Cell Transplant. [PMID: 31370690] (WB, Rat)
• Lim J, Park H, Heisler J et al. Autophagy regulates inflammatory programmed cell death via turnover of RHIM-domain proteins Elife 2019-07-09 [PMID: 31287416] (WB, Mouse)
• Lloyd AF, Davies CL, Holloway RK et al. Central nervous system regeneration is driven by microglia necroptosis and repopulation Nat. Neurosci. 2019-07-01 [PMID: 31182869]
• Font-Belmonte E, Ugidos IF, Santos-Galdiano M et al. Post-ischemic salubrinal administration reduces necroptosis in a rat model of global cerebral ischemia J. Neurochem. 2019-06-05 [PMID: 31165478] (Rat)
• Li X, Gong W, Wang H et al. O-GlcNAc Transferase Suppresses Inflammation and Necroptosis by Targeting Receptor-Interacting Serine/Threonine-Protein Kinase 3 Immunity 2019-02-05 [PMID: 30770249] (WB, Human)
• Wu Z, Fournel L, Stadler N et al. Modulation of lung cancer cell plasticity and heterogeneity with the restoration of cisplatin sensitivity by Neurotensin antibody Cancer Lett. 2018-12-21 [PMID: 30583074]
• Hernandez D E, Salvadores N A et al. Axonal degeneration induced by glutamate excitotoxicity is mediated by necroptosis. J Cell Sci 2018-11-19 [PMID: 30333135] (WB, Rat)
• Hou H, Wang Y, Li Q et al. The role of RIP3 in cardiomyocyte necrosis induced by mitochondrial damage of myocardial ischemia-reperfusion. Acta Biochim. Biophys. Sin. (Shanghai) 2018-09-12 [PMID: 30215665] (WB, Rat)
• Generation and Use of Chimeric RIP Kinase Molecules to Study Necroptosis Rodriguez DA, Green DR. Methods Mol Biol. [PMID: 30136231] (WB, Mouse)
• Chen T, Pan H, Li J et al. Inhibiting of RIPK3 attenuates early brain injury following subarachnoid hemorrhage: Possibly through alleviating necroptosis Biomed. Pharmacother. 2018-08-13 [PMID: 30114640] (WB, ICC/IF, Rat)
• Li P, Zhou Y, Goodwin AJ et al. Fli-1 Governs Pericyte Dysfunction in a Murine Model of Sepsis. J. Infect. Dis. 2018-07-20 [PMID: 30053030] (WB, Mouse)
• Zamaraev AV, kopeina GS, Buchbinder JH et al. Caspase-2 is a negative regulator of necroptosis. Int. J. Biochem. Cell Biol. 2018-07-17 [PMID: 30025878] (WB, Human)
• Piao X, Miura R, Miyake S et al. Blockade of TNF receptor superfamily 1 (TNFR1)-dependent and TNFR1-independent cell death is crucial for normal epidermal differentiation. J. Allergy Clin. Immunol. 2018-03-27 [PMID: 29596938] (Mouse)
• Feldmann Friederike, Schenk Barbara, Martens Sofie et al. Sorafenib inhibits therapeutic induction of necroptosis in acute leukemia cells. Oncotarget 2017-01-01 [PMID: 28978109] (WB, Human)
• Martens S, Jeong M, Tonnus W et al. Sorafenib tosylate inhibits directly necrosome complex formation and protects in mouse models of inflammation and tissue injury Cell Death Dis 2017-06-29 [PMID: 28661484] (WB, Mouse)
• Sridharan H, Ragan KB, Guo H et al. Murine cytomegalovirus IE3-dependent transcription is required for DAI/ZBP1-mediated necroptosis EMBO Rep. 2017-06-12 [PMID: 28607035] (Mouse)
• Gong YN, Guy C, Olauson H et al. ESCRT-III Acts Downstream of MLKL to Regulate Necroptotic Cell Death and Its Consequences. Cell. 2017-04-06 [PMID: 28388412] (Mouse)
• Ros U, Pena-Blanco A, Hanggi K et al. Necroptosis Execution Is Mediated by Plasma Membrane Nanopores Independent of Calcium. Cell Rep 2017-04-04 [PMID: 28380356] (WB, Mouse)
• Yang SH, Lee DK, Shin J et al. Nec-1 alleviates cognitive impairment with reduction of Abeta and tau abnormalities in APP/PS1 mice. EMBO Mol Med. 2016-11-17 [PMID: 27861127] (WB, IP, Mouse)
• Shindo R, Yamazaki S, Ohmuraya M et al. Short form FLICE-inhibitory protein promotes TNFalpha-induced necroptosis in fibroblasts derived from CFLARs transgenic mice. Biochem. Biophys. Res. Commun. 2016-11-04 [PMID: 27721066] (GS, Mouse)
• Qin D, Wang X, Li Y et al. MiR-223-5p and -3p Cooperatively Suppress Necroptosis in Ischemic/Reperfused Hearts. J. Biol. Chem. 2016-08-08 [PMID: 27502281] (WB, Mouse)
• Lloyd AF Cellular and molecular mechanisms underpinning microglial activation during remyelination Thesis [PMID: 27446913] (ICC/IF, IF/IHC, Mouse, Rat, Human)
• Seo J, Lee EW, Sung H et al. CHIP controls necroptosis through ubiquitylation- and lysosome-dependent degradation of RIPK3 Nat. Cell Biol. 2016-03-01 [PMID: 26900751] (WB, IP, Human, Mouse)
• Wertz IE, Newton K, Seshasayee D et al. Phosphorylation and linear ubiquitin direct A20 inhibition of inflammation. Nature. 2015-12-17 [PMID: 26649818] (WB, Mouse)
• Yoon S, Bogdanov K, Kovalenko A, Wallach D et al. Necroptosis is preceded by nuclear translocation of the signaling proteins that induce it Cell Death Differ. 2015-07-17 [PMID: 26184911] (WB, Mouse)
• Miki Y, Akimoto J, Moritake K et al. Photodynamic therapy using talaporfin sodium induces concentration-dependent programmed necroptosis in human glioblastoma T98G cells Lasers Med Sci. 2015-06-25 [PMID: 26109138] (WB, Human)
• Dara L, Johnson H, Suda J et al. Receptor Interacting protein kinase-1 mediates murine acetaminophen toxicity independent of the necrosome and not through necroptosis Hepatology. 2015-06-16 [PMID: 26077809] (WB, Mouse)
• Preyat N, Rossi M, Kers J et al. Intracellular nicotinamide adenine dinucleotide promotes TNF-induced necroptosis in a sirtuin-dependent manner. Cell Death Differ. 2016-01-01 [PMID: 26001219] (WB, Human)
• Gautheron J, Vucur M, Reisinger F et al. A positive feedback loop between RIP3 and JNK controls non-alcoholic steatohepatitis. EMBO Mol Med. 2014-06-24 [PMID: 24963148] (WB, Mouse)
  
  Details:
  Figs 1B, S1, S11: RIPK3-/- and WT liver, Fig S10C: L929 fibrosarcoma cells. RIPK3 was detected between the 50 and 60 kDa marker. The specificity of the RIPK3 pAb was validated using RIPK3-/- and WT mouse liver by WB (Figs 1B, S11).
• Orozco S, Yatim N, Werner MR et al. RIPK1 both positively and negatively regulates RIPK3 oligomerization and necroptosis. Cell Death Differ. 2014-06-06 [PMID: 24902904] (WB, Mouse)
  
  Details:
  Figs 4b, S1B, S1I: Jaxson immortalized fibroblasts (Jax) and NIH3T3 cells transfected with RIPK3 fusion constructs (RIPK3-NIH3T3). RIPK3 was detected at ~50 kDa in Jax and at ~70 kDa in RIPK3-NIH3T3 cells. The specificity of the RIPK3 pAb was validated in RIPK3-NIH3T3 cells by WB (Figs 4b, S1B, S1I). Note: According to the authors, NIH3T3 cells do not expression endogenous RIPK3.
• Berger SB, Kasparcova V, Hoffman S et al. Cutting Edge: RIP1 kinase Activity Is Dispensable for Normal Development but Is a key Regulator of Inflammation in SHARPIN-Deficient Mice. J. Immunol. 2014-05-12 [PMID: 24821972] (WB, Mouse)
  
  Details:
  Bone marrow-derived macrophages, Fig 1C.
• Dillon CP, Weinlich R, Rodriguez DA et al. RIPk1 Blocks Early Postnatal Lethality Mediated by Caspase-8 and RIPk3. Cell. 2014-05-22 [PMID: 24813850] (WB, Mouse)
  
  Details:
  Mouse embryo fibroblasts, Figs 6D, 6H, S4D, S6A, S6D.
• Piao X, Komazawa-Sakon S, Nishina T et al. c-FLIP maintains tissue homeostasis by preventing apoptosis and programmed necrosis. Sci Signal. 2012-12-18 [PMID: 23250397] (WB)
  
  Details:
  WB: Fig 1B: primary RIPK3 knockout and wildtype mouse embryo fibroblasts (MEF) and 3T3-SA cells. Fig 2F: 3T3-SA Fig S1D: various tissues from RIPK3 knockout and wildtype mice, 3T3-SA Fig S3C: SVEC cells expressing RIPK3 siRNA or scrambled siRNA Fig SCD: N
• Dillon CP, Oberst A, Weinlich R et al. Survival function of the FADD-CASPASE-8-cFLIP(L) complex. Cell Rep. 2012-05-31 [PMID: 22675671]
• Oberst A, Dillon CP, Weinlich R et al. Catalytic activity of the caspase-8-FLIP(L) complex inhibits RIPK3-dependent necrosis. Nature. 2011-03-17 [PMID: 21368763]
• Kim JY, Kim YJ, Lee S, Park JH. BNip3 is a mediator of TNF-induced necrotic cell death. Apoptosis. 2011-02-01 [PMID: 20963496] (WB)
  
  Details:
  RIP3 (IMG-5523-1 & 5523-2). WB: A549 cells treated or untreated with TNF-alpha, Fig 4D.
• Kaiser WJ, Upton JW, Mocarski ES. Receptor-interacting protein homotypic interaction motif-dependent control of NF-kappa B activation via the DNA-dependent activator of IFN regulatory factors. J Immunol. 2008-11-01 [PMID: 18941233] (WB, Mouse, Human)
  
  Details:
  WB [human 293T cells (2), mouse L929 cells (4)], Figs. 2A-C; 4B.

Review for RIPK3/RIP3 Antibody (NBP1-77299) (1)

Average Rating: 5

(Based on 1 review)

We have 1 review tested in 1 species: L929 cells.

reviewed by: Verified Customer WB L929 cells 05/04/2020

Summary

• Application: Western Blot
• Sample Tested: 20 ug whole cell lysate
• Species: L929 cells
• Lot: 8337-1701

Comments

• Comments: L929 cell line
  Primary antibody: 1:2000,
  Secondary antibody: 1:20000

FAQs for RIPK3/RIP3 Antibody (NBP1-77299). (Showing 1 - 5 of 5 FAQs).

1. What research areas can this product be used in?
   • All RIPK3/RIP3 products can be used in: Cancer, Cell Biology, Immunology, Necroptosis, Protein Kinase, Signal Transduction.
2. What is the theoretical molecular weight for your RIPK3/RIP3 antibodies?
   • This depends on the immunogen. We have one RIPK3/RIP3 antibody [NBP1-77299] that is raised against murine RIP3. The theoretical molecular weight for this product is 53 kDa. The rest of our RIPK3/RIP3 antibodies are developed against human RIP3 and have a theoretical molecular weight of 56.7 kDa.
3. If this product is used in an application or species as a part of a customer review, will that validate this product in the application/species?
   • If any of our primary antibodes are used in an untested application or species and it is shown to work through images from customer reviews or through publications, this validates the application/species for this product. Please check out our Innovator's Reward Program if you decide to test an antibody with a species or application that is not currently listed.
4. I am currently looking for a good antibody working as an ELISA capture antibody for mouse RIP3. Would you let me know if this application was tested during the development of your NovusBio (NBP1-77299) antibody.
   • Our product NBP1-77299 has been validated for use in ELISA. We tested this product in a direct ELISA format; it has not yet been tested in a sandwich ELISA format. The immunogen used to make this product falls between amino acids 473 to 486 of the mouse protein. If your detection antibody is outside of this range, it is possible that this combination will yield positive results.
5. What human isoforms can be detected by this antibody?
   • RIPK3/RIP3 Antibody [NBP1-77299] can detect human isoform 1. This antibody can also detect isoforms of mouse and rat.

Bioinformatics

• Gene Symbol: RIPK3
• Entrez:
  • 6063101(Mouse)
• Uniprot:
  • AAF03133(Mouse)